Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute

About this trial

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder; or families in which the individual has a lymphoproliferative disorder, and an unusual clustering of frequent or premature solid tumors is also observed.

Family members of the individual, either affected or unaffected with lymphoma, who are contacted by the individual and agree to participate in the study.

Deceased family members may be included in the study. Public records such as death certificates may be used to confirm the history. Consent for medical records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next of kin is spouse, offspring, parents and siblings. Archived tissue samples may be used for genetic research.

Age > 18 years

Disqualifiers

Subjects without a family history of lymphoma

Trial population

Group 1: Next of kin of a relative who has died from lymphoma Group 2: Subjects who have a next of kin diagnosed with lymphoma and/or CLL Group 3: Subjects who have had or have non-Hodgkin's lymphoma, CLL or Hodgkin's disease and had a relative who also had lymphoma or CLL

Trial design

Design model

Family-based

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,500 Participants
are grouped into 3 trial groups
Group A: Next of Kin of deceased subj by lymphoma
Group B: Subject unaffected by lymphoma
Group C: Subject affected by lymphoma

Trial outcomes

Primary outcomes

1

Genetic factors that contribute to the development of lymphomas and CLL

Genetic factors that contribute to the development of lymphomas and CLL

Time frame
Indefinite

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.